Bloomlife Pregnancy Monitor: Wearable Contraction and Fetal Movement Tracker

Pregnant women have been told to “count the contractions” for generations, but timing contractions with a stopwatch during active labor is like measuring a hurricane with a rain gauge. A wearable sensor that continuously monitors uterine activity offers a fundamentally different kind of prenatal intelligence.

Presented By Our Partners

The third trimester of pregnancy is medically defined by anticipation: waiting for labor to begin, wondering whether contractions are “real” or Braxton Hicks, trying to determine when to call the obstetrician, and navigating the anxiety of not knowing what is happening inside your body. Clinically, uterine contraction monitoring is a routine component of hospital-based labor assessment, performed using tocodynamometry (external pressure sensors strapped to the abdomen). But this monitoring is available only during scheduled prenatal visits or after hospital admission. Between appointments, pregnant women rely on subjective perception: timing contractions manually, noting fetal movement patterns, and making judgment calls about when activity warrants clinical attention. Bloomlife was designed to bridge this gap, providing continuous, wearable contraction monitoring and fetal movement tracking that extends hospital-grade awareness into the home environment during the final weeks of pregnancy.

What Is Bloomlife?

Bloomlife is a wearable pregnancy monitor consisting of a small sensor pod that attaches to the abdomen using a disposable adhesive patch. The sensor detects uterine electrical activity (electrohysterography) through surface electrodes, measuring contraction frequency, duration, and interval patterns. It also tracks fetal movement and maternal heart rate. Data transmits via Bluetooth to a companion smartphone app that displays contraction patterns in real time, provides contraction timing and counting, and tracks fetal movement trends over time.

The device is designed for use during the third trimester, typically from 32 weeks onward, when Braxton Hicks contractions become more frequent and the distinction between practice contractions and early labor becomes clinically relevant. Bloomlife does not diagnose preterm labor, and it is not intended to replace clinical monitoring. It provides data that helps pregnant women and their providers make more informed decisions about when contraction patterns warrant clinical evaluation.

Bloomlife costs approximately $249 for the sensor device plus $49 per month for the subscription service, totaling approximately $588 per year if used for the full third trimester (approximately 8 weeks of typical use would cost closer to $349). The device is FDA registered as a general wellness product. It is not FDA cleared for medical contraction monitoring or fetal monitoring, which distinguishes it from hospital-grade tocodynamometry and electronic fetal monitoring systems.

The Science Behind Contraction Monitoring and Fetal Movement Tracking

Uterine contractions are generated by the coordinated electrical activation of myometrial smooth muscle cells. During pregnancy, the uterus transitions from a quiescent state (maintained by progesterone) to an increasingly contractile state as parturition approaches. Braxton Hicks contractions, which occur irregularly throughout the second and third trimesters, represent uncoordinated myometrial activity that does not produce cervical change. True labor contractions are characterized by increasing frequency, duration, regularity, and intensity, ultimately producing the coordinated force that dilates the cervix and delivers the baby.

Electrohysterography (EHG), the technology underlying Bloomlife’s sensor, measures the electrical signals generated by myometrial cells through surface electrodes placed on the abdomen. Research has demonstrated that EHG provides a more direct measurement of uterine contractile activity than traditional tocodynamometry, which measures abdominal pressure changes as a proxy for contractions. Several studies have explored EHG’s potential for predicting preterm labor, with some research showing that EHG signal characteristics (frequency content, propagation velocity, and burst duration) differ between contractions that lead to preterm delivery and those that do not.

Fetal movement monitoring has a long clinical history. Maternal perception of fetal movement (“kick counts”) has been a standard component of third-trimester prenatal care since the 1970s. Decreased fetal movement can signal fetal distress, growth restriction, or placental insufficiency. However, maternal subjective perception of fetal movement is imprecise: research shows that women detect only a fraction of actual fetal movements, and perception varies with maternal activity, fetal position, and placental location. Objective fetal movement monitoring through wearable sensors offers the potential for more consistent and complete movement data.

The clinical significance of contraction pattern analysis extends beyond labor onset detection. Preterm labor (before 37 weeks) is the leading cause of neonatal morbidity and mortality in the United States, affecting approximately 10% of pregnancies. Early identification of abnormal contraction patterns could, in theory, prompt earlier clinical intervention. However, the evidence linking home contraction monitoring to improved preterm birth outcomes is mixed, and guidelines from professional organizations do not currently recommend routine home uterine activity monitoring for low-risk pregnancies.

That is the science. Here is how Bloomlife applies it.

What Bloomlife Does Well

Bloomlife’s core value proposition is replacing subjective contraction awareness with objective measurement. The difference between “I think I am having contractions” and “the sensor shows contractions every 7 minutes lasting 45 seconds” is the difference between anxiety and information. For first-time mothers who have never experienced labor, the ability to see contraction patterns visualized in real time provides a grounding reference point that no amount of prenatal education can replicate.

The electrohysterography approach is scientifically more direct than pressure-based tocodynamometry. By measuring the electrical activity that drives contractions rather than the surface pressure contractions produce, EHG potentially captures contractile events that external pressure sensors miss, particularly in women with higher body mass index where tissue thickness attenuates pressure signals.

The app’s contraction pattern visualization transforms raw data into interpretable information: contraction frequency, duration, and interval are displayed graphically, making it easy to identify whether contractions are becoming more regular and frequent (suggesting labor progression) or remaining irregular (suggesting Braxton Hicks). This pattern recognition is exactly what obstetricians assess during labor triage, and having objective data to report during a phone call to the provider’s office can improve the quality of clinical decision-making.

Fetal movement tracking provides an additional data stream that complements contraction monitoring. Trends in fetal movement frequency over days and weeks can be shared with providers as objective evidence of fetal wellbeing or as documentation supporting a concern about decreased movement.

Featured Partner

Invest in the Infrastructure Behind Modern Medicine

As healthcare expands beyond hospital walls, the buildings and campuses supporting that shift are generating compelling returns for investors who move early. The Healthcare Real Estate Fund offers qualified investors direct access to a curated portfolio of medical office, outpatient, and specialty care facilities.

Learn More →

Pricing, Access, and Practical Realities

Bloomlife costs approximately $249 for the sensor device plus $49 per month for the subscription. For a typical 8-week third-trimester use period, total cost would be approximately $641 ($249 + 8 months at $49, though most users subscribe for 2 to 3 months, totaling $347 to $396). This is a significant investment for a device with a limited use window.

The device is FDA registered as a general wellness product. It is not FDA cleared for medical contraction monitoring, fetal monitoring, or preterm labor detection. This regulatory status means Bloomlife cannot make medical claims about its ability to diagnose labor, detect fetal distress, or improve pregnancy outcomes. The device provides informational data that supplements, but does not replace, clinical prenatal monitoring.

Bloomlife is not currently confirmed as HSA or FSA eligible. Insurance coverage for home pregnancy monitoring devices varies by plan and is not standard.

The adhesive patches are consumable and require regular replacement. The sensor pod is reusable for the duration of the pregnancy. Patch comfort and adhesion quality vary with skin type, body habitus, and activity level. Some users report skin irritation from prolonged adhesive wear.

Who Bloomlife Is Best For

Bloomlife is best suited for third-trimester pregnant women who experience significant anxiety about contraction patterns and fetal movement. First-time mothers who have no experiential reference for distinguishing Braxton Hicks from early labor may find the objective data particularly reassuring. Women with a history of preterm labor or preterm birth who are hyperaware of uterine activity during subsequent pregnancies may use Bloomlife to monitor patterns and communicate more effectively with their care providers.

The device appeals to data-oriented women who are already tracking other health metrics (via Oura, Apple Watch, or similar devices) and want their pregnancy monitoring to match the same level of quantified detail.

Low-risk pregnant women with no anxiety about contractions or fetal movement may find the investment unnecessary. Women at high risk for preterm labor should be under direct clinical supervision with hospital-grade monitoring rather than relying on consumer devices. Bloomlife should never be used as a substitute for emergency medical evaluation when a pregnant woman suspects labor, significant bleeding, decreased fetal movement, or any acute concern.

How Bloomlife Compares

Hospital-based tocodynamometry and electronic fetal monitoring (EFM) remain the clinical standard for contraction and fetal heart rate monitoring. These systems are FDA cleared, clinically validated, and staffed by trained nurses. Bloomlife cannot match the diagnostic capability or clinical oversight of hospital monitoring. Its value lies in extending data collection into the home environment between clinical visits, not replacing in-hospital assessment.

Manual contraction timing (using a stopwatch or contraction timer app) is free and requires no hardware. These apps record user-reported contraction start/stop times and calculate intervals. The limitation is that they depend entirely on the user’s subjective perception of when contractions begin and end, which can be unreliable. Bloomlife’s sensor provides objective contraction detection without subjective timing.

Owlet Band (if available) represents another wearable pregnancy monitoring approach, combining contraction tracking with fetal heart rate monitoring. Availability and regulatory status vary. The consumer pregnancy monitoring category is nascent, with limited competition and limited clinical evidence base.

Limitations and Open Questions

The most significant limitation is the lack of FDA clearance for medical monitoring. Bloomlife is a general wellness device, which means it has not undergone the clinical validation required for medical contraction monitoring or fetal monitoring claims. Pregnant women and their providers should not make clinical decisions (such as when to go to the hospital) based solely on Bloomlife data.

The evidence supporting home uterine activity monitoring for improving pregnancy outcomes is inconclusive. A Cochrane review of home uterine activity monitoring for preterm labor prevention found no clear benefit in reducing preterm birth rates. This does not mean the data is useless for individual decision-making, but it means the population-level health impact of consumer pregnancy monitors has not been established.

The $49/month subscription model for a device used over a limited timeframe (typically 6 to 12 weeks) makes Bloomlife one of the higher cost-per-use consumer health devices. Users should evaluate whether the objective contraction data provides sufficient value over free contraction timer apps and standard kick count protocols.

Sensor placement, adhesive quality, and signal clarity can vary. Abdominal fat distribution, fetal position, and skin conditions affect the quality of EHG signal capture. Some users may experience periods of poor signal quality that limit data utility.

What This Means for Your Health

Pregnancy is among the most physiologically demanding experiences in human biology. Blood volume increases by 40 to 50%. Cardiac output rises by 30 to 50%. The immune system undergoes selective suppression. Every organ system adapts to support fetal development, and the third trimester represents the peak of these adaptations. Monitoring the body during this period is not optional; it is standard medical care delivered through prenatal visits. Bloomlife extends this monitoring into the home, providing continuous data where previously there was only intermittent clinical assessment.

Within Healthcare Discovery‘s Five Pillars, pregnancy monitoring connects to sleep (third-trimester sleep disruption is universal and influenced by contraction patterns), movement (physical activity during pregnancy affects contraction frequency and fetal movement patterns), nutrition (maternal metabolic health influences fetal growth and uterine activity), and mindset (reducing the anxiety of uncertainty through objective data supports maternal mental health).

The longevity context extends beyond the mother. Preterm birth is associated with increased lifelong health risks for the child, including cardiovascular disease, metabolic dysfunction, and neurodevelopmental challenges. Technologies that contribute to identifying preterm labor risk earlier, even incrementally, serve the healthspan of two generations simultaneously.

Bloomlife does not replace obstetric care. It provides a new data layer that can inform conversations between pregnant women and their care teams. For women who find the uncertainty of late pregnancy anxiety-inducing, that data layer has genuine value. For the field of maternal health technology, Bloomlife represents an early entry into a category that will likely expand as wearable biosensing technology matures and clinical validation studies accumulate.

Frequently Asked Questions

Is Bloomlife FDA cleared for medical monitoring?
No. Bloomlife is FDA registered as a general wellness device. It is not FDA cleared for medical contraction monitoring, fetal monitoring, or preterm labor detection. The device provides informational data about uterine contraction patterns and fetal movement but should not replace clinical prenatal monitoring or be used for medical decision-making without consulting a healthcare provider.

How much does Bloomlife cost?
Bloomlife costs approximately $249 for the sensor device plus $49 per month for the subscription service. For a typical 2 to 3 month third-trimester use period, total cost ranges from approximately $347 to $396. The adhesive patches are consumable and require regular replacement, adding a minor additional cost.

When should I start using Bloomlife?
Bloomlife is designed for third-trimester use, typically starting around 32 weeks of pregnancy. This is when Braxton Hicks contractions become more noticeable and the distinction between practice contractions and early labor becomes clinically relevant. Some users begin earlier in the third trimester for extended baseline data.

Can Bloomlife tell me if I am in labor?
No. Bloomlife displays contraction patterns (frequency, duration, interval) that can help you and your provider assess whether contractions are becoming more regular and frequent, which are characteristics of labor progression. However, confirming active labor requires clinical assessment including cervical examination. Always contact your healthcare provider or go to the hospital if you suspect labor is beginning.

Does Bloomlife monitor the baby’s heart rate?
Bloomlife tracks fetal movement patterns but does not monitor fetal heart rate. Hospital-based electronic fetal monitoring (EFM) uses Doppler ultrasound to continuously track fetal heart rate, which Bloomlife’s surface electrode technology does not replicate. Fetal heart rate monitoring remains a clinical assessment performed during prenatal visits and labor.

Free Daily Briefing

The Latest Longevity Science.
Delivered Every Morning.

Join researchers, physicians, and health professionals getting daily breakthroughs in AI-driven medicine, epigenetics, and longevity research.

Support the research that powers this editorial

Subscribe Free

No spam. Unsubscribe anytime. We respect your inbox.